JACKSONVILLE, Fla. , Sept. 20, 2023 /PRNewswire/ -- Global shipping and energy supply chain leader Crowley has teamed with nuclear power leader BWX Technologies, Inc. (NYSE: BWXT) through a memorandum of understanding for a ship concept that has the potential to generate alternative, zero-carbon emission energy for defense and... Read More

Effort Will Leverage U.S. Department of Energy Advanced Reactor Demonstration Program Achievements LYNCHBURG, Va. / Sep 12, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) today announced a two-phase, two-year contract with the Wyoming Energy Authority to assess the viability of deploying small-scale nuclear reactors in the state as a source of resilient and reliable energy to augment existing power generation... Read More

Under Initial Award of $47 Million, BWXT Will Process NNSA Scrap Material Into Usable HALEU LYNCHBURG, Va. / Aug 30, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) today announced a contract to process thousands of kilograms of government-owned scrap material containing enriched uranium that is unusable in its present form in order to produce more than two metric tons of feedstock that can be used for fuel to... Read More

2Q23 revenues of $612.4 million 2Q23 net income of $58.7 million, adjusted EBITDA (1) of $107.0 million 2Q23 diluted GAAP EPS of $0.64, non-GAAP (1) EPS of $0.65 Selected to provide the nuclear system and fuel for DARPA's DRACO project, the first nuclear powered spacecraft Shipped final missile tube of the Block II contract from our Mount Vernon facility Narrowing 2023 non-GAAP (1) EPS guidance to $2.85-$3.00 LYNCHBURG, Va.... Read More

CAMBRIDGE, Ontario / Aug 02, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with TerraPower to design the Intermediate Heat Exchanger for the Natrium Demonstration Project. The Natrium technology is a 345-megawatt sodium fast reactor coupled with a molten salt-based integrated energy storage system. The Intermediate Heat Exchanger is a critical component of the Natrium advanced reactor.... Read More

DRACO Program Will Demonstrate Nuclear Power’s Ability to Propel Spacecraft LYNCHBURG, Va. / Jul 26, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) today announced that its reactor and fuel will be key components in the world’s first demonstration spacecraft using nuclear thermal propulsion. Working as part of a... Read More

LYNCHBURG, Va. / Jun 27, 2023 / Business Wire / BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2023 results on Thursday, August 3, 2023, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants... Read More

1Q23 revenue of $568.4 million 1Q23 net income of $61.0 million, adjusted EBITDA (1) of $110.7 million 1Q23 diluted GAAP EPS of $0.67, non-GAAP (1) EPS of $0.70 Awarded a $428 million, five-year contract by the National Nuclear Security Administration (NNSA) to provide purification and conversion services for highly enriched uranium. BWXT-led JV chosen to provide environmental management operations for the DOE’s Hanford... Read More

LYNCHBURG, Va. / Apr 17, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington. The DOE announced that the Hanford Integrated Tank Disposition Contract (ITDC) was awarded to Hanford Tank Waste Operations &... Read More

LYNCHBURG, Va. / Apr 10, 2023 / Business Wire / BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has been awarded a $428 million contract from the National Nuclear Security Administration (NNSA) to provide purification and conversion services for highly enriched uranium (HEU). Located in Erwin, Tennessee, NFS is one of only two Category I nuclear facilities licensed by... Read More

LYNCHBURG, Va. / Apr 05, 2023 / Business Wire / BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing first quarter 2023 results on Monday, May 8, 2023, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced an engineering contract awarded by GE Hitachi Nuclear Energy (GEH) for its BWRX-300 small modular reactor (SMR) reactor pressure vessel (RPV). The RPV, which contains the reactor core and associated internals, comprises the largest component within the BWRX-300. Work associated with the contract includes engineering analysis, design support, manufacturing and procurement... Read More

BWX Technologies, Inc. (NYSE: BWXT) has released its 2023 Sustainability Report, demonstrating the company’s deep involvement in environmental restoration, clean energy, global security, community investment and many other initiatives critical to environmental, social and governance (ESG) excellence. “This report is a cross-section of our sustainability, safety, inclusion and operational accomplishments,” said Rex Geveden,... Read More

4Q22 diluted GAAP EPS of $0.47, diluted non-GAAP (1) EPS of $0.93, on revenue of $624.2 million 4Q22 net income of $43.0 million, adjusted EBITDA (1) of $130.1 million 2022 diluted GAAP EPS of $2.60, diluted non-GAAP (1) EPS of $3.13, on revenue of $2.23 billion 2022 net income of $238.6 million, adjusted EBITDA (1) of $439.4 million 2022 operating cash flow of $244.7 million, free cash flow (1) of $46.4 million Initiates... Read More

Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station, thanks to the installation and initial commissioning of an innovative isotope system by Laurentis Energy Partners and BWXT Medical Ltd. (NYSE: BWXT). The production of Mo-99 at Darlington will be a world-first for a commercial power reactor. With the necessary equipment now installed , the... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing fourth quarter and full-year 2022 results on Thursday, February 23, 2023, after market close and will host a conference call at 5:00 p.m. EST. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.) 1-844-200-6205,... Read More

Agreement augments Fusion's existing isotope supply as pipeline of clinical stage actinium-based radiopharmaceuticals grows Furthers BWXT Medical's position as a global leader in medical isotope supply HAMILTON, ON , Jan. 5, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), and BWXT Medical Ltd. , a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), today announced that the companies have entered into a preferred... Read More

BWX Technologies, Inc. (NYSE: BWXT) has promoted Ronald O. (Chip) Whitford, Jr. to the position of senior vice president, general counsel, chief compliance officer and corporate secretary, effective January 2, 2023. Whitford is succeeding Thomas E. McCabe, who will serve as special advisor to the CEO until his retirement on August 1, 2023. Whitford joined the company in 2017 and most recently has served as vice president,... Read More

BWX Technologies, Inc . (NYSE: BWXT) today with officials from the U.S. Department of Defense, Department of Energy, NASA and Idaho National Laboratory celebrated the landmark production of TRISO nuclear fuel that will power the first microreactor built and operated in the United States. The Department of Energy (DOE) calls TRISO “the most robust nuclear fuel on earth.” The small, energy-dense coated uranium particles can... Read More

3Q22 revenue of $523.7 million 3Q22 net income of $61.8 million, adjusted EBITDA (1) of $100.1 million 3Q22 diluted GAAP EPS of $0.67, non-GAAP (1) EPS of $0.69 3Q22 net cash provided by operating activities of $65.0 million, free cash flow (1) of $25.4 million Narrows 2022 guidance and anticipates strong revenue and EBITDA (1) growth in 2023 Technetium 99-m generator application accepted by FDA with priority review... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that management will be participating and presenting at three upcoming investor conferences before the end of the year. Nov. 9 Baird 2022 Global Industrial Conference – Chicago Management attending: Rex Geveden, president and chief executive officer; Robb LeMasters, senior vice president and chief financial officer; Joseph Miller, president BWXT Advanced Technologies,... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for diagnostic imaging. Once approved for commercial production by regulatory bodies, BWXT Medical’s new proprietary manufacturing technology will be used to irradiate molybdenum targets at an... Read More

BWX Technologies, Inc. (NYSE: BWXT) has appointed Robert (Bob) Duffy as senior vice president and chief administrative officer (CAO). In this role, he will have full responsibility for human resources and a number of other business support functions. “Bob has an extraordinary track record of leading and building large scale, complex businesses and will be a superb addition to our senior leadership team,” said Rex Geveden,... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2022 revenue of $554 million, a 10% increase compared with $505 million in the second quarter 2021. GAAP net income for the second quarter 2022 was $74.6 million, or $0.82 per diluted share, compared with net income of $59.3 million, or $0.62 per diluted share, in the prior-year period. Non-GAAP (1) net income for the second... Read More

BWX Technologies, Inc . (NYSE: BWXT) has appointed Sharon H. Smoot as president of BWXT’s Nuclear Operations Group, Inc. (NOG). In this role, she will have full responsibility for NOG’s mission to provide a complete range of nuclear components and services, including the manufacture of nuclear reactor components for U.S. Navy submarines and aircraft carriers and other nuclear and non-nuclear R&D and component production.... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.) 844-200-6205 and (International)... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Power’s Major Component Replacement (MCR) Project. The contract is for the fabrication and supply of replacement feeders for Bruce Power’s reactor units 3, 4, 5, 7 and 8 and represents an integral part of Bruce Power’s MCR Project. Feeder tube assemblies in CANDU® reactors transport... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225). Today’s announcement follows the agreement reached by the two companies in September 2021. Under the terms of the commercial agreement, Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices. The parties expect... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes. This agreement will enable BWXT Medical to manufacture high purity Actinium-225 (Ac-225) based products for pharmaceutical companies as it continues to build... Read More

BWX Technologies, Inc. (NYSE: BWXT) will build the first advanced nuclear microreactor in the United States under a contract awarded by the U.S. Department of Defense (DoD) Strategic Capabilities Office (SCO). The Project Pele full-scale transportable microreactor prototype will be completed and delivered in 2024 for testing... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2022 revenue of $531 million, a slight increase compared with $528 million in the first quarter 2021. GAAP net income for the first quarter 2022 was $59.0 million, or $0.64 per diluted share, compared with GAAP net income of $69.7 million, or $0.73 per diluted share, in the prior-year period. Non-GAAP (1) net income for the first... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that Jan A. Bertsch has been elected as its new chair of the board of directors, effective May 3, 2022, succeeding retiring board chairman John A. Fees. Bertsch has served as an independent director of BWXT since 2013, and she was most recently the chair of its audit and finance committee and a member of the compensation committee. She also serves on the board of directors... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing first quarter 2022 results on Monday, May 9, 2022, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.) 844-850-0542 and (International)... Read More

BWX Technologies, Inc . (NYSE: BWXT) today announced the release of its 2022 Sustainability Report. The report reviews the company’s environmental, social and governance (ESG) achievements and describes how BWXT uses its nuclear expertise to deliver safe and effective solutions to address some of the world’s most important problems in areas as diverse as global security, clean energy, environmental restoration, nuclear... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that the U.S. Naval Nuclear Propulsion Program has exercised contract options totaling approximately $1 billion for manufacturing naval nuclear reactor components and fuel. “BWXT is gratified to continue to support the U.S. Navy as the sole manufacturer of naval nuclear reactors and fuel for U.S. submarines and aircraft carriers,” BWXT Nuclear Operations Group, Inc.... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that it has streamlined its reporting segment structure to better reflect its operations and position the company for improved efficiency and strategic growth. Starting with the first quarter of 2022, BWXT will report as two operating segments called Government Operations and Commercial Operations. The company has named Kevin M. McCoy president of the Government Operations... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported fourth quarter 2021 revenue of $592 million, a 6% increase compared with $557 million in the fourth quarter 2020. GAAP net income for the fourth quarter 2021 was $117 million, or $1.26 per diluted share, compared with GAAP net income of $65.7 million, or $0.69 per diluted share, in the prior-year period. Non-GAAP net income for the fourth... Read More

BWX Technologies, Inc. (NYSE: BWXT) is hosting an Investor Day 8:30 a.m. to approximately 11:30 a.m. ET on Tuesday, Nov. 16, 2021. During the event, BWXT executives will discuss current operations and future vision across the company’s portfolio of businesses. There will also be a question and answer session following prepared remarks. Among the presenters will be: Rex Geveden, President and Chief Executive Officer Robb... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that as part of BWXT’s executive succession planning process, Robb A. LeMasters has been named senior vice president and chief financial officer effective November 15, 2021. LeMasters will succeed David S. Black, who will retire after 30 years of service to BWXT. Black began at BWXT as general accounting manager for the Nuclear Environmental Services Division. He assumed... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2021 revenue of $499 million, down 4% compared with $520 million in the third quarter 2020. GAAP net income for the third quarter 2021 was $59.9 million, or $0.63 per diluted share, compared with GAAP net income of $73.2 million, or $0.76 per diluted share, in the prior-year period. Non-GAAP net income for the third quarter 2021... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Savannah River Site (SRS) in South Carolina. The DOE announced the award of the Savannah River Site Integrated Mission Completion Contract to Savannah River Mission Completion, LLC (SRMC),... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing third quarter 2021 results on Monday, November 1, 2021, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.) 844-850-0542 and (International)... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products. Ac-225 is a highly powerful... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers. The contract, which will be executed by subsidiary BWXT Canada Ltd. at its Cambridge, Ontario facility, involves engineering and fabrication of these specialized components. Moderator heat exchangers are large components that remove heat from the moderator system of... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2021 revenue of $505 million, about even compared with $505 million in the second quarter 2020. Net income for the second quarter 2021 was $59.3 million, or $0.62 per diluted share, compared with GAAP net income of $64.3 million, or $0.67 per diluted share and non-GAAP net income of $67.7 million, or $0.71 per diluted share, in... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2021 results on Monday, August 2, 2021, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.) 844-850-0542 and (International)... Read More

TTM Technologies, Inc. (NASDAQ: TTMI), a leading global printed circuit board (“PCB”) and radio frequency (“RF”) components and assemblies manufacturer, announced today that Robert E. Klatell has retired from his position as Chairman of the Board and Board member of TTM in accordance with TTM’s Corporate Governance Policy that proscribes a mandatory retirement for Directors at the age of 75. Mr. Klatell has served as a... Read More

BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company. Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions of glass microspheres containing radioactive Yttrium-90, which are... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2021 revenue of $528 million, a 2.6% decrease compared with $542 million in the first quarter 2020. Net income for the first quarter 2021 was $69.7 million, or $0.73 per diluted share, compared with GAAP net income of $75.5 million, or $0.79 per diluted share and non-GAAP net income of $75.6 million, or $0.79 per diluted share,... Read More

BWX Technologies, Inc. (NYSE: BWXT) has expanded its existing technical fellows initiative by selecting 25 additional employees for the program in recognition of their scientific and engineering accomplishments at the company. Individuals selected as fellows are recognized as senior technical experts and leaders who are in a position to offer ongoing technical advice to other staff and review new products and technology... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will webcast a discussion of its first quarter 2021 results on Tuesday, May 4, 2021, at 9:00 a.m. EDT. The company will issue a press release detailing the results after market close on Monday, May 3. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for participants are (U.S.)... Read More

BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”) announced today the closing of its previously announced offering of $400 million aggregate principal amount of 4.125% senior notes due 2029 (the “Notes”) in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”). The Notes are guaranteed by each of BWXT’s present and future direct and indirect wholly owned domestic... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract extension, valued at up to $690 million including options, from the U.S. Department of Energy (DOE) for environmental management work at Portsmouth Gaseous Diffusion Plant. The agreement took effect on March 29, 2021, and includes a one-year extension with two additional six-month options. Cleanup work at the site has been conducted by joint venture Fluor-BWXT... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that it is continuing its groundbreaking Nuclear Thermal Propulsion (NTP) design, manufacturing development, and test support work for NASA. NTP is one of the technologies that is capable of propelling a spacecraft to Mars, and this contract continues BWXT’s work that began in 2017. Under the terms of a $9.4 million, one-year contract awarded to its BWXT Advanced... Read More

BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”) announced today that it has priced its previously announced offering of $400 million aggregate principal amount of 4.125% senior notes due 2029 (the “Notes”) in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”). The Notes will be guaranteed by each of BWXT’s present and future direct and indirect wholly owned... Read More

BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”) announced today that it plans to offer up to $400 million aggregate principal amount of senior notes due 2029 (the “Notes”) in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”). The Notes will be guaranteed by each of BWXT’s present and future direct and indirect wholly owned domestic subsidiaries that is a... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced a $28 million, 12-month contract award from the Department of Defense’s (DoD) Strategic Capabilities Office (SCO) for the final design of a transportable microreactor prototype under the second phase of its Project Pele initiative. SCO is partnering with the U.S. Department of Energy to develop, prototype and demonstrate a mobile microreactor that can be used to provide... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Nuclear Operations Group, Inc. (BWXT NOG) subsidiary has been awarded a total of $35 million in contracts under two separate programs – uranium recovery and conversion as well as construction of a new research reactor fuel line. “These awards showcase BWXT’s unique capabilities in processing and manufacturing nuclear fuels, our long history fueling research... Read More

BWXT Medical Ltd. (BWXT Medical) and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific (Asia). BWXT Medical is a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and a global supplier of medical isotopes and radiopharmaceuticals. GMS is a global operator of centralized radiopharmacies, manufacturer and... Read More

BWX Technologies, Inc. (NYSE: BWXT) announced today that Chief Financial Officer David Black will be presenting at the virtual J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on Monday, March 1, 2021. BWXT is a leading supplier of nuclear components, fuel and services to government and commercial customers and is the sole manufacturer of U.S. naval nuclear reactors for submarines and aircraft carriers. The... Read More

BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported record revenue in the fourth quarter 2020 at $557 million, an 11% increase compared with $501 million in the fourth quarter 2019. GAAP net income for the fourth quarter 2020 was $65.7 million, or $0.69 per diluted share, compared with GAAP net income of $61.4 million, or $0.64 per diluted share, in the prior-year period. Non-GAAP net income... Read More

BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy. BWXT’s entry into the nuclear medicine industry began with the development of a new breakthrough technology that will enable the production of molybdenum-99 and... Read More

BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will webcast a discussion of its fourth quarter 2020 results on Tuesday, February 23, 2021, at 9:00 a.m. EST. The company will issue a press release detailing the results after market close on Monday, February 22. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors . The dial-in numbers for... Read More